Long-term Safety and Tolerability of Once-daily Mesalamine Granules in the Maintenance of Remission of Ulcerative Colitis

Renal Effects of Long-Term Treatment with 5-Aminosalicylic Acid

(2016) Harshna Patel et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database

(2013) Jean Lachaine et al.   BMC GASTROENTEROLOGY

Mesalazine granules 1.5 g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two randomised controlled trials

(2012) G. R. Lichtenstein et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Ulcerative colitis

(2012) Ingrid Ordás et al.   LANCET

Mesalamine in the treatment and maintenance of remission of ulcerative colitis

(2012) Maggie Ham et al.   Expert Review of Clinical Pharmacology

Strategies in maintenance for patients receiving long-term therapy (SIMPLE): A study of MMX mesalamine for the long-term maintenance of quiescent ulcerative colitis*

(2011) Sunanda Kane et al.   INFLAMMATORY BOWEL DISEASES

Clinical trial: once-daily mesalamine granules for maintenance of remission of ulcerative colitis - a 6-month placebo-controlled trial

(2010) G. R. Lichtenstein et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

(2010) Asher Kornbluth et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Hepatotoxicity of Agents Used in the Management of Inflammatory Bowel Disease

(2010) Omar S. Khokhar et al.   DIGESTIVE DISEASES

Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis

(2010) William J. Sandborn et al.   GASTROENTEROLOGY

Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis

(2009) Axel U. Dignass et al.   Clinical Gastroenterology and Hepatology

5-ASA in ulcerative colitis: Improving treatment compliance

(2009) Cosimo Prantera et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis

(2008) M A Kamm et al.   GUT

Therapeutic strategies for the management of ulcerative colitis

(2008) Siew C. Ng et al.   INFLAMMATORY BOWEL DISEASES

Quality of life of patients with ulcerative colitis: Past, present, and future

(2007) Jan E. Irvine   INFLAMMATORY BOWEL DISEASES